Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases-Reference-Cited by-同舟云学术

Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases

Published:2021-12-01 Issue:4 Volume:2 Page:213-216
ISSN:2719-4523
Container-title:Rheumatology and Immunology Research
language:en
Short-container-title:

Author:

Shen Min¹,Dong Lingli²,Li Mengtao¹,Zhao Yan¹,Zeng Xiaofeng¹

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College ; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing , China

2. Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College , Huazhong University of Science and Technology , Wuhan , China

Abstract

Abstract Vaccination against coronavirus disease 2019 (COVID-19) has been promoted all over the world and has become an important measure to control the pandemic. Patients with rheumatic diseases are at high risk of 2019-nCoV severe infection, hence are the target population with high priority for vaccination. In 2021, under the leadership of the Chinese Rheumatology Association, the recommendations on SARS-CoV-2 vaccination for adult patients with rheumatic diseases in China were proposed based on the current data, in combination with international guidelines and experts’ opinions.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.2478/rir-2021-0029/pdf

Reference5 articles.

1. Akiyama S, Hamdeh S, Micic D, et al. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021;80(3):384–391.

2. Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1. Arthritis Rheumatology (Hoboken, NJ). 2021;73(10):e60–e75.

3. Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39–52.

4. Bijlsma JW. EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs. Ann Rheum Dis. 2021;80(4):411–412.

5. Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. Hamostaseologie 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity;Arthritis Care & Research;2023-07-20

2. A cross‐sectional study of dermatologists' attitudes towards COVID ‐19 vaccination in patients with immunobullous diseases;Journal of the European Academy of Dermatology and Venereology;2022-10-29